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ABSTRACT: While more commonly associated with plants
than microbes, diterpenoid natural products have been
reported to have profound eﬀects in marine microbe−microbe
interactions. Intriguingly, the genome of the marine bacterium
Salinispora arenicola CNS-205 contains a putative diterpenoid
biosynthetic operon, terp1. Here recombinant expression
studies are reported, indicating that this three-gene operon
leads to the production of isopimara-8,15-dien-19-ol (4).
Although 4 is not observed in pure cultures of S. arenicola, it is
plausible that the terp1 operon is only expressed under certain
physiologically relevant conditions such as in the presence of other marine organisms.
The production of terpenoids is most commonly associatedwith plants, which have clearly expanded their ability to
produce this class of natural products. For example, terpene
synthases form moderate sized gene families, with more than 10
such enzymatic genes found in each of the known vascular
plant genome sequences.1 By contrast, there appear to be just
over 100 terpene synthases among the more than 1000
sequenced bacterial genomes, suggesting the relative scarcity of
terpene synthases and, hence, terpenoid production, among
commonly studied bacterial genera.2
This relative paucity of bacterial terpenoid production is also
illustrated by the labdane-related diterpenoids, a large super-
family of ∼7000 known natural products whose biosynthesis is
characterized by the initiating reaction. Speciﬁcally, acid−base
catalyzed bicyclization of the general diterpenoid precursor
(E,E,E)-geranylgeranyl diphosphate (GGPP, 1), which is
mediated by class II diterpene cyclases that generally form
the eponymous labdadienyl/copalyl diphosphate (CPP). This is
typically followed by an additional cyclization and/or rearrange-
ment reaction initiated by ionization of the allylic diphosphate
catalyzed by a class I diterpene synthase.3 All vascular plants
have at least one class II diterpene cyclase in order to produce
the requisite gibberellin phytohormones, and many plant
species have multiple such enzymes.4 However, less than 100
class II diterpene cyclases are present in the known bacterial
genomes5 and less than 10 have been characterized.6−12
Nevertheless, there are a handful of bacteria that produce
labdane-related diterpenoids of signiﬁcant interest. The relevant
class II diterpene cyclases have been identiﬁed for a number of
these bacterial natural products, including such enzymes
involved in the production of gibberellin phytohormones by
plant symbiotic rhizobia and phytopathogens,9,11,12 the
potential antibacterial and antidiabetic compounds platencin
and platensimycin by Streptomyces platensis,10 and an immuno-
modulatory factor by Mycobacterium tuberculosis.8 Intriguingly,
it has been reported that an epiphytic marine bacterium
produces a labdane-related diterpenoid that acts at subpico-
molar levels to promote the aggregation of marine green
macroalgae (e.g., sea lettuce).13
With the advent of next generation sequencing, there has
been a tremendous increase in the availability of microbial
genome sequences,14 which has generally revealed that there
are many more putative natural product biosynthetic gene
clusters than known metabolites.15 A variety of approaches have
been taken toward identifying the compounds resulting from
such orphan operons.16 Here is reported the use of
recombinant expression to characterize a bioinformatics-
predicted labdane-related diterpenoid biosynthetic operon
from the marine bacterium Salinispora arenicola CNS-205.
The genome sequence of the CNS-205 strain of the widely
distributed marine actinobacterium S. arenicola was previously
reported, with bioinformatic analysis indicating the presence of
30 putative natural product biosynthetic gene clusters.17
Included among these was terp1, annotated as producing an
unidentiﬁed diterpene. This small operon contains genes
encoding a putative class II diterpene cyclase (Sare_1288)
and class I (di)terpene synthase (Sare_1287) as well as a
cytochrome P450 (CYP) mono-oxygenase (Sare_1286) that
has been assigned as CYP1051A1 (Figure 1). Thus, the terp1
Received: May 23, 2014
Published: September 9, 2014
Note
pubs.acs.org/jnp
© 2014 American Chemical Society and
American Society of Pharmacognosy 2144 dx.doi.org/10.1021/np500422d | J. Nat. Prod. 2014, 77, 2144−2147
operon is predicted to encode for the production of a labdane-
related diterpenoid, although this appears to be unique to the
originally sequenced CNS-205 strain,17 as similar sequences do
not seem to be present in the other 36 strains whose genome
sequences have recently been reported.18
The putative class II diterpene cyclase is most closely related
to two previously characterized ent-CPP synthases (CPSs) from
Streptomyces species of terrestrial actinobacteria (42−45%
amino acid sequence identity)7,10 and is referred to henceforth
as SaCPS. While class II diterpene cyclases almost invariably
contain a DxDD motif that cooperatively acts as the catalytic
acid,19 SaCPS contains a Thr in place of the last Asp
(Supporting Information (SI), Figure S1). Such a variant
DxDT motif has been previously noted in the active class II
diterpene cyclase from M. tuberculosis,8 suggesting that SaCPS
might be functional.
Similarly, the putative class I diterpene synthase is most
closely related to a previously characterized ent-pimaradiene
synthase from Streptomyces sp. KO-3988 (∼30% amino acid
sequence identity)20 and is referred to henceforth as SaDTS.
Although class I terpene synthases almost invariably contain a
DDxxD motif involved in binding the requisite divalent
magnesium ion cofactors,21 SaDTS does not contain a
corresponding sequence. Amino acid sequence alignments
indicate that the corresponding sequence in SaDTS is
EDWQVD83−88 instead (SI, Figure S2). While the ent-kaurene
synthase from S. platensis also does not have the canonical
DDxxD motif at this position, sequence conforming to the
DDxxD motif can be found nearby,10 which is not true in
SaDTS. On the other hand, SaDTS does contain the
NDxxSxxxE motif also involved in binding the requisite
divalent magnesium ion co-factors,21 leaving open the
possibility that SaDTS may be active as well.
Characterization of the bioinformatics-predicted labdane-
related diterpenoid product of this operon was undertaken with
a previously developed modular metabolic engineering
system.22 This enabled recombinant expression of SaCPS
with a GGPP synthase (GGPS) in Escherichia coli, which led to
the production of CPP, observed as the dephosphorylated
copalol by GC-MS analysis of hexane extracts of the induced
culture (Figure 2A). To determine the absolute conﬁguration
of this CPS, SaCPS was co-expressed with GGPS and selective
class I diterpene synthases, much as previously described for
investigation of other class II diterpene cyclases. Brieﬂy, SaCPS
and the GGPS were co-expressed with either the ent-kaurene
synthase from Arabidopsis thaliana (AtKS) that selectively
reacts with ent-CPP,9 or a mutant of the abietadiene synthase
from Abies grandis (AgAS) that no longer exhibits class II
activity and only reacts with normal CPP (AgAS:D404A).23 No
ent-kaurene was observed upon co-expression of SaCPS (and
GGPS) with AtKS, while the same products made by wild-type
AgAS were readily observed upon co-expression with
AgAS:D440A (SI, Figure S3). Thus, SaCPS makes normal
(5S,9S,10S) CPP (2).
Co-expression of SaDTS with GGPS and SaCPS led to
production of an unknown diterpene, observed by GC-MS
analysis of hexane extracts of the induced culture. To determine
the structure of this compound, SaDTS was co-expressed with
GGPS and a plant CPS in E. coli (Figure 2B), which produces
larger quantities of 2 (i.e., than SaCPS), and the culture volume
was increased to 2 L. This enabled isolation of ∼2 mg for NMR
analysis (SI, Figures S4−S6 and Table S1), which indicated that
this was a (iso)pimara-8,15-diene, with resolution of the
conﬁguration at C-13 derived from comparison to previously
reported NMR chemical shift data,24,25 which led to assignment
of the SaDTS product as isopimara-8,15-diene (3).
To functionally characterize CYP1051A1, it was necessary to
account for the fact that CYPs require the input of electrons,
generally obtained from NADPH, and in the case of bacterial
CYPs typically provided by a ferredoxin (Fdx) that has been
reduced by a ferredoxin reductase (FdR).26 Accordingly,
CYP1051A1 was co-expressed with an Fdx and FdR from S.
arenicola (Sare_4141 and Sare_0646, respectively) in a strain of
Figure 1. Schematic of the terp1 diterpenoid biosynthetic operon from
S. arenicola CNS-205.
Figure 2. GC-MS extracted ion (m/z = 257) chromatograms and associated mass spectra for (A) production of CPP (2), detected as
dephosphorylated copalol (2′; retention time, RT = 17.16 min), from expression of SaCPS in a strain of E. coli engineered to make GGPP (1) by
SaCPS. (B) Isopimara-8,15-diene (3; RT = 15.27 min) from expression of SaDTS in a strain engineered to make 2. (C) Isopimara-8,15-dien-19-ol
(4; RT = 17.04 min) from co-expression of CYP1051A1 with an Fdx and Fdr in a strain engineered to make 3.
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E. coli also engineered to produce 3. The resulting recombinant
strain produced a hydroxylated derivative of 3, observed by
GC-MS analysis of an organic solvent extract (Figure 2C).
Attempts to scale up production of the CYP1051A1 product
were not fruitful, with a net yield of only ∼100 μg from 5 L of
culture. Fortuitously, it was discovered that CYP99A3 from
rice27 catalyzed the same reaction (SI, Figure S7) and was more
amendable to scale-up. Thus, CYP99A3 was used to produce
enough compound (∼1 mg), which was mixed with the ∼0.1
mg isolated from CYP1051A1 for NMR analysis (SI, Figures
S4, S8, and S9 and Table S2). Only a single peak was found in
the alcohol region of the 13C spectra (SI, Figure S9), consistent
with equivalence of the CYP99A3 and CYP1051A1 products,
which the collected data indicated was isopimara-8,15-dien-19-
ol (4). The conﬁguration at C-4 was suggested by the
observation of an NOE signal between the secondary alcohol
hydrogens on C-19 and the methyl hydrogens of C-20, whose
conﬁguration was already known (vide supra) and veriﬁed by
comparison to previously reported NMR chemical shift data.28
Thus, the S. arenicola terp1 operon presumably can lead to the
production of isopimara-8,15-dien-19-ol (Scheme 1).
It has been previously reported that at least two species of
Streptomyces grown in certain media produce the diterpenoid
viguiepinol (3α-hydroxy-ent-pimara-9(11),15-diene) and de-
rived oxaloterpins, which are very similar to 4.29,30 To
determine whether terp1 pathway metabolites were produced
by S. arenicola CNS-205, this actinomycete was fermented in
four diﬀerent media (SI), and chemical extracts were evaluated
by GC-MS with selected ion monitoring for 3 and 4. None of
the evaluated fermentation conditions aﬀorded production of 3
or 4 at levels detectable by GC-MS. Chemical proﬁles were also
compared among wild type S. arenicola CNS-205 and PCR-
targeted terp1 gene replacement mutants to facilitate the
detection of terp1 operon-derived metabolites that are modiﬁed
by additional enzymes in vivo. No diﬀerences in GC-MS or LC-
MS metabolite proﬁles were noted for extracts from wild type S.
arenicola CNS-205, a sare_1286::AprR mutant lacking the
CYP1051A1 cytochrome P450 enzyme and a sare_1287::AprR
mutant lacking the DTS class I (di)terpene synthase enzyme.
These data suggest that the terp1 gene cluster is either inactive
in S. arenicola CNS-205 under evaluated conditions or that
diterpenoid titers are below the limit of detection.
In conclusion, functional characterization of the orphan terp1
biosynthetic operon from S. arenicola is reported here. While
the terp1 operon is only found in strain CNS-205, these results
further illuminate the natural products capacity of these widely
distributed marine actinobacteria. Although the resulting
diterpenoid 4 cannot be found in pure cultures of S. arenicola
CNS-205 grown in a variety of media, it is possible that 4 serves
an ecological function and is only produced by S. arenicola
CNS-205 under speciﬁc environmental conditions (e.g., in the
presence of other organisms). Alternatively, it has been
previously noted that all other characterized bacterial
diterpenoid biosynthetic operons contain a GGPS as bacteria
do not generally produce 1 otherwise,7,10,12,31−36 and the lack
of a GGPS in the S. arenicola CNS-205 terp1 operon may
underlie the observed lack of production of 4. In any case, these
results demonstrate the applicability of the utilized modular
metabolic engineering system to elucidation of (di)terpenoid
biosynthetic operons uncovered by genome mining of actino-
and potentially other bacteria as well.
■ EXPERIMENTAL SECTION
General Experimental Procedures. NMR spectroscopic data
were recorded on a Bruker Avance 500 spectrometer equipped with
cryogenic probe for 1H and 13C measurements (Bruker). GC-MS
analyses were carried out using a Varian 3900 GC with Saturn 2100
ion trap mass spectrometer equipped with HP-5 ms capillary column
(30 m × 0.25 mm × 0.25 μm) in electron ionization (70 eV) mode
(Agilent/Varian). Column chromatography was performed with 80 ×
200 mesh silica gel (Fisher Scientiﬁc). HPLC was carried out with a
ZORBAX Eclipse XDB-C8 column (4.6 mm × 150 mm, 5 μm) on an
Agilent 1100 series system equipped with fraction collector and diode
array detector. Solvents for chromatographic separations were
purchased from Fisher Scientiﬁc.
Methods Summary. The genes from S. arenicola described herein
were cloned from the fosmids used in its genome sequencing project.17
These were cloned into the Gateway vector system (Invitrogen) to
enable their use in the metabolic engineering system, including co-
expression with previously characterized enzymes (i.e., to investigate
conﬁgurations or increase yield). Enzymatic products were analyzed by
GC-MS of organic extracts from the relevant recombinant cultures.
Where necessary (i.e., for 3 and 4), these cultures were scaled up to
enable production and puriﬁcation of larger quantities for structural
characterization by NMR.
Isopimara-8,15-diene (3). Previously described as a colorless
solid;37,38 1H and 13C NMR, as well as MS, data largely match
literature values,24,25,39 with the few signiﬁcant diﬀerences supported
here by HMBC correlations (SI, Table S1).
Isopimara-8,15-dien-19-ol (4). Previously described as a colorless
solid;38 1H and 13C NMR data largely match literature values,28 again
with the few signiﬁcant diﬀerences supported here by HMBC
correlations (SI, Table S2).
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